Cytokine production by human herpesvirus 8-infected dendritic cells

被引:23
作者
Hensler, Heather R. [1 ]
Rappocciolo, Giovanna [1 ]
Rinaldo, Charles R. [1 ,2 ]
Jenkins, Frank J. [1 ,2 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
关键词
EFFUSION LYMPHOMA-CELLS; KAPOSIS-SARCOMA; DC-SIGN; HUMAN-HERPESVIRUS-8; RESPONSES; DIFFERENTIATION; MACROPHAGES; ACTIVATION; PHENOTYPE; INFECTION;
D O I
10.1099/vir.0.006239-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
We have shown previously that human herpesvirus 8 (HHV-8)-infected dendritic cells (DCS) undergo incomplete maturation and have a defective antigen-presenting function. Here, we examined the effects of HHV-8 infection on cytokine production, which is critical to the function of DCs. We detected expression of interleukin (IL)-6, tumour necrosis factor (TNF)-alpha, macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, RANTES and IL-12p40 from 2 to 6 h post-infection, and these peaked by 15-24 h. Expression of these factors decreased 24-48 h post-infection, with the exception of TNF-alpha. which remained high throughout the entire 72 In. Interestingly, while IL-12p40 expression increased post-infection, bioactive IL-12p70 was not detected in the supernatants. These results suggest an intentional skewing of cytokine production in HHV-8-infected DCs towards induction of a Th2 response.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 26 条
[1]
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells [J].
Asou, H ;
Said, JW ;
Yang, R ;
Munker, R ;
Park, DJ ;
Kamada, N ;
Koeffler, HP .
BLOOD, 1998, 91 (07) :2475-2481
[2]
Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments [J].
Baghian, A ;
Luftig, M ;
Black, JB ;
Meng, YX ;
Pau, CP ;
Voss, T ;
Pellett, PE ;
Kousoulas, KG .
VIROLOGY, 2000, 269 (01) :18-25
[3]
Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus [J].
Brander, C ;
Suscovich, T ;
Lee, Y ;
Nguyen, PT ;
O'Connor, P ;
Seebach, J ;
Jones, NG ;
van Gorder, M ;
Walker, BD ;
Scadden, DT .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2077-2083
[4]
Brockmeyer N H, 1999, Eur J Med Res, V4, P95
[5]
DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production [J].
Caparros, Esther ;
Munoz, Pilar ;
Sierra-Filardi, Elena ;
Serrano-Gomez, Diego ;
Puig-Kroeger, Amaya ;
Rodriguez-Fernandez, Jose L. ;
Mellado, Mario ;
Sancho, Jaime ;
Zubiaur, Mercedes ;
Corbi, Angel L. .
BLOOD, 2006, 107 (10) :3950-3958
[6]
Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production [J].
Chung, YH ;
Means, RE ;
Choi, JK ;
Lee, BS ;
Jung, JU .
JOURNAL OF VIROLOGY, 2002, 76 (10) :4688-4698
[7]
Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells [J].
Cirone, Mara ;
Lucania, Giuseppe ;
Aleandri, Silvia ;
Borgia, Giuliana ;
Trivedi, Pankaj ;
Cuomo, Laura ;
Frati, Luigi ;
Faggioni, Alberto .
IMMUNOLOGY LETTERS, 2008, 120 (1-2) :37-41
[8]
Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity [J].
Cirone, Mara ;
Lucania, Giuseppe ;
Bergamo, Paola .
IMMUNOLOGY LETTERS, 2007, 113 (01) :40-46
[9]
Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals [J].
de Jong, EC ;
Vieira, PL ;
Kalinski, P ;
Schuitemaker, JHN ;
Tanaka, Y ;
Wierenga, EA ;
Yazdanbakhsh, M ;
Kapsenberg, ML .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :1704-1709
[10]
Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma [J].
Della Bella, Silvia ;
Nicola, Stefania ;
Brambilla, Lucia ;
Riva, Antonio ;
Ferrucci, Silvia ;
Presicce, Pietro ;
Boneschi, Vinicio ;
Berti, Emilio ;
Villa, Maria Luisa .
CLINICAL IMMUNOLOGY, 2006, 119 (03) :317-329